Abacus Global Management, Inc. - Class A Common Stock (ABL)
5.4500
-0.0400 (-0.73%)
NASDAQ · Last Trade: Jun 23rd, 5:02 PM EDT
Detailed Quote
Previous Close
5.490
Open
5.430
Bid
5.350
Ask
5.740
Day's Range
5.350 - 5.605
52 Week Range
5.100 - 11.86
Volume
969,289
Market Cap
-
PE Ratio (TTM)
-
EPS (TTM)
-
Dividend & Yield
N/A (N/A)
1 Month Average Volume
1,721,615
Chart
About Abacus Global Management, Inc. - Class A Common Stock (ABL)
Abacus Life, Inc. is a financial services company that specializes in the acquisition and management of life insurance policies. The company focuses on providing liquidity solutions for policyholders through life settlements, where individuals can sell their life insurance policies for a lump sum payment. Abacus Life aims to transform the life insurance marketplace by offering consumers alternative financing options while also investing in life insurance assets to generate returns for its investors. Through its innovative approach, the company seeks to create value by unlocking the potential of life insurance as an asset class. Read More
US~Observer, a national investigative news outlet known for exposing corruption and defending the wrongly accused, has launched a probe into Morpheus Research , a recently formed short-report entity endorsed by Hindenburg Research founder Nate Anderson. The investigation follows a string of Morpheus reports targeting Solaris Energy Infrastructure (NYSE: SEI) , Backblaze (NASDAQ: BLZE) , Abacus Global Management (NASDAQ: ABL) , and Mercurity Fintech Holding (NASDAQ: MFH) —each followed by steep stock drops ranging from 5% to more than 30%.
NEW YORK, June 23, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Abacus Global Management, Inc. (“Abacus” or the “Company”) (NASDAQ: ABL). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
ORLANDO, Fla., June 23, 2025 (GLOBE NEWSWIRE) -- Abacus Global Management, Inc. (“Abacus” or the “Company”) (NASDAQ: ABL), a leader in the alternative asset management space, announced the public launch of their new corporate-focused commercial campaign on June 12th, 2025, at their Investor Day and Longevity Summit held at Nasdaq in New York City.
NEW YORK CITY, NY / ACCESS Newswire / June 20, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Abacus Global Management, Inc. ("Abacus" or the "Company") (NASDAQ:ABL). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
SAN FRANCISCO, CA / ACCESS Newswire / June 18, 2025 / Abacus Global Management, Inc. (NASDAQ:ABL) is under mounting pressure as its stock continues to slide, driven by a series of damning reports from Morpheus Research-a newly formed investigative group led by analysts who previously worked at the renowned Hindenburg Research. Despite Abacus's public denials and the announcement of a $20 million share repurchase program, investor confidence remains shaken, with shares now down more than 36% over the past month.
NEW YORK, June 18, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Abacus Global Management, Inc. (“Abacus” or the “Company”) (NASDAQ: ABL). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
NEW YORK, June 16, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Apple Inc. (NASDAQ:AAPL), Sable Offshore Corp. (NYSE:SOC), and Abacus Global Management, Inc. (NASDAQ:ABL). Our investigations concern whether these companies have violated the federal securities laws and/or engaged in other unlawful business practices. Additional information about each case can be found at the link provided.
SAN FRANCISCO, CA / ACCESS Newswire / June 16, 2025 / Investors in Abacus Global Management, Inc. (NASDAQ:ABL) experienced another substantial decline in share price today following the release of a second scathing report from Morpheus Research. Morpheus, a collective of financial analysts known for their focus on uncovering alleged fraud and corporate malfeasance, has now published two critical analyses of Abacus within a week, alleging the life settlements company has engaged in improper accounting.
NEW YORK, June 15, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Abacus Global Management, Inc. (“Abacus” or the “Company”) (NASDAQ: ABL). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
NEW YORK, June 10, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Abacus Global Management, Inc. (“Abacus” or the “Company”) (NASDAQ: ABL). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
NEW YORK, June 09, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against GoHealth, Inc. (NASDAQ:GOCO) and Abacus Global Management, Inc. (NASDAQ:ABL). Our investigations concern whether these companies have violated the federal securities laws and/or engaged in other unlawful business practices. Additional information about each case can be found at the link provided.
The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Abacus Global Management, Inc. (“Abacus” or “the Company”) (NASDAQ: ABL) for violations of the securities laws.
NEW YORK, NY - June 7, 2025 ( NEWMEDIAWIRE ) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Abacus Global Management, Inc. (“Abacus” or the “Company”) (NASDAQ: ABL).
NEW YORK, June 06, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Abacus Global Management, Inc. (“Abacus” or the “Company”) (NASDAQ: ABL). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
Abacus Global Management Inc. (NASDAQ: ABL) shares are trading higher Friday after the company announced a $20 million share repurchase program and disclosed insider buying totaling over $2 million.
NEW YORK, June 05, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Abacus Global Management, Inc. (“Abacus” or the “Company”) (NASDAQ:ABL) on behalf of Abacus stockholders. Our investigation concerns whether Abacus has violated the federal securities laws and/or engaged in other unlawful business practices.
Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Abacus Global Management, Inc. (“Abacus” or the “Company”) (NASDAQ: ABL) investors concerning the Company’s possible violations of the federal securities laws.
Law Offices of Howard G. Smith announces an investigation on behalf of Abacus Global Management, Inc. (“Abacus” or the “Company”) (NASDAQ: ABL) investors concerning the Company’s possible violations of federal securities laws.
The Law Offices of Frank R. Cruz announces an investigation of Abacus Global Management, Inc. (“Abacus” or the “Company”) (NASDAQ: ABL) on behalf of investors concerning the Company’s possible violations of federal securities laws.
NEW YORK, NY - June 5, 2025 ( NEWMEDIAWIRE ) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Abacus Global Management, Inc. (“Abacus” or the “Company”) (NASDAQ: ABL).
Shares of Abacus Global Management, Inc. (“Abacus”) fell over 30% in intraday trading on Wednesday, June 4, 2025, after Morpheus Research published an article alleging that the financial services company is a “life settlements accounting scheme manufacturing fake revenue by systematically underestimating when people will die.” Gibbs Mura is investigating a potential Abacus Global Management, Inc. (NASDAQ: ABL) Securities Class Action Lawsuit on behalf of shareholders who lost money in Abacus.
NEW YORK, NY - June 4, 2025 ( NEWMEDIAWIRE ) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Abacus Global Management, Inc. (“Abacus” or the “Company”) (NASDAQ: ABL).
